MedTrace Logo

Pharmacological Interaction of Rifampicin on Clindamycin in Staphylococcic Osteoarticular Infections

NCT02782078 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-03-27

No results posted yet for this study

Summary

Clindamycin and rifampicin are authorized in osteoarticular infection treatment (IDSA guidelines) but some interaction is observed. The objective of this study is to evaluate and quantify rifampicin interaction on clindamycin

Conditions

  • Staphylococcal Infections

Interventions

BIOLOGICAL

Clindamycin and rifampicin dosages

blood samples for clindamycin and rifampicin dosages (for each patient)

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Tiphaine Goulenok, MD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-06
Primary Completion
2018-12-12
Completion
2019-01-03

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02782078 on ClinicalTrials.gov